MedDataX Logo

Asphyxia Associated Metabolite Biomarker Investigation 2

NCT ID: NCT04714502

Last Updated: 2021-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

144 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-02

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Follow-up of participants of AAMBI1 study at age of at least 2 years. AAMBI1(ClinicalTrials.gov ID: NCT03354208): Verification of biomarkers in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

THE ROLE OF CARDIAC MARKERS IN HYPOXIC ISCHEMIC ENCEPHALOPATHY IN LONG-TERM NEURODEVELOPMENTAL FOLLOW UP

NCT04766541

Hypoxic-Ischemic Encephalopathy Newborn Morbidity
UNKNOWN

Optimization and Clinical Study of Early Prediction Model for Neonatal Acute Respiratory Distress Syndrome

NCT05647850

Neonatology
RECRUITING

Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)

NCT03311165

Neonatal Acute Respiratory Distress Syndrome(ARDS)
COMPLETED

The Association Between LPCAT1 Genetic Polymorphism and Stress Biomarkers in Neonatal Respiratory Distress Syndrome

NCT04947215

Neonatal Respiratory Distress
UNKNOWN

Asphyxia at Birth : Causes and Neonatal Outcome

NCT03227536

Neonatal Asphyxia
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Follow-Up on neuro-developmental status of Study participants of AAMBI1. AAMBI1(ClinicalTrials.gov ID: NCT03354208): The aim of the study is to verify the application of combinations of several laboratory parameters in early postnatal blood samples, for identification of infants, who will suffer from early abnormal neonatal neurological outcome, in a population at risk. The population at risk is defined as term and late preterm (\>36 weeks of gestation) human infants following perinatal hypoxia-ischemia with or without postnatal resuscitation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Birth Asphyxia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Infants enrolled in AAMBI1

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants previously enrolled in the AAMBI1 study

Exclusion Criteria

* Missing valid written informed parental consent
Minimum Eligible Age

22 Months

Maximum Eligible Age

48 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cukurova University

OTHER

Sponsor Role collaborator

University Children's Hospital Tuebingen

OTHER

Sponsor Role collaborator

InfanDx AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ron Meyer

Role: STUDY_DIRECTOR

InfanDx AG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Turkey Cukurova University

Adana, , Turkey (Türkiye)

Site Status

University of Firat

Elâzığ, , Turkey (Türkiye)

Site Status

Özel Güngören Hastanesi

Istanbul, , Turkey (Türkiye)

Site Status

Mersin University School of Medicine

Mersin, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAMBI2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life
NCT00425581 WITHDRAWN
Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants
NCT01763632 COMPLETED
Urine NT-ProBNP in Neonatal Respiratory Distress
NCT02020993 UNKNOWN
Prediction of Jaundice in Term Infants
NCT01203410 COMPLETED
Measuring Serum Level of Total L Carnitine in HIE and TTN
NCT04546321 COMPLETED
Studying Fetal Breathing Patterns
NCT00066976 COMPLETED
Thoracic Fluid Content by Electric Bioimpedance Versus Lung Ultrasound in Preterm Neonates With Respiratory Distress
NCT05594030 UNKNOWN
Study of Energy Requirements in Critically Ill Newborns
NCT00006274 UNKNOWN
Biomarkers and Volumetric Capnography in BPD
NCT02083562 COMPLETED
Maternal and Neonatal Risk Factors of HIE
NCT05749458 UNKNOWN
Brain Volumes of Very Low Birth Weight Infants Measured by Cranial Ultrasonography
NCT02848755 COMPLETED
Prediction of Neonatal Respiratory Distress Syndrome in Preterm Fetuses by Assessment of Fetal Lung Volume by Vocal and Pulmonary Artery Resistance Index a Pilot Study
NCT02283138 COMPLETED
PATET Ratio to Rule Out Transient Tachypnea of the Newborn
NCT02965365 COMPLETED
Childhood Measures of NICU-based Chemical Exposure
NCT02292680 WITHDRAWN
Follow-up Results of Newborns With Tracheostomy
NCT04497740 UNKNOWN
Fluid Restriction in Respiratory Distress of the Newborn
NCT03120585 COMPLETED NA
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
NCT01607216 COMPLETED
First Breath: Neonatal Resuscitation in Developing Countries
NCT00136708 COMPLETED NA
Multi-center Clinical Study on Neonatal Hyperbilirubinemia
NCT03824990 COMPLETED NA
Substantial Equivalence Study for Kai Medical Non-Contact Respiratory Rate Monitors for Use With Neonates
NCT01324817 UNKNOWN
Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2
NCT02700854 COMPLETED PHASE1
Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates
NCT04538079 TERMINATED
Neonate Cerebral Activity in Immediate Post Partum
NCT04225975 UNKNOWN NA
Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.
NCT04359134 UNKNOWN
NHFOV as Primary Support in Very Preterm Infants With RDS
NCT05141435 COMPLETED NA